Cell Engineering and Cultivation of Chinese Hamster Ovary (CHO) Cells

被引:130
作者
Omasa, Takeshi [1 ]
Onitsuka, Masayoshi [1 ]
Kim, Wook-Dong [1 ]
机构
[1] Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka 5650871, Japan
关键词
Chinese hamster ovary (CHO) cell; cell line development; cultivation process; post-translational process; bacterial artificial chromosome (BAC) library; glycosylation control; omics technology; mammalian cell; RECOMBINANT PROTEIN-PRODUCTION; HUMAN ANTITHROMBIN-III; MAMMALIAN-CELLS; ANTIBODY-PRODUCTION; PRODUCTIVITY; CULTURE; OVEREXPRESSION; HYBRIDOMA; SYSTEMS; GROWTH;
D O I
10.2174/138920110791111960
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mammalian cell lines are important host cells for the industrial production of pharmaceutical proteins owing to their capacity for correct folding, assembly and post-translational modification. In particular, Chinese hamster ovary (CHO) cells are the most dependable host cells for the industrial production of therapeutic proteins. Growing demand for therapeutic proteins promotes the development of technologies for high quality and productivity in CHO expression systems. The following are fundamentally important for effective production. 1) Construction of cultivation process. The CHO-based cultivation process is well established and is a general platform of therapeutic antibody production. The cost of therapeutic protein production using CHO cells is equivalent to that using microbial culture. 2) Cell line development. Recent developments in omics technologies have been essential for the development of rational methods of constructing a cell line. 3) Cell engineering for post-translational steps. Improvement of secretion, folding and glycosylaiton is an important key issue for mammalian cell production systems. This review provides an overview of the industrial production of therapeutic proteins using a CHO cell expression system.
引用
收藏
页码:233 / 240
页数:8
相关论文
共 55 条
[1]   Activating transcription factor 4 [J].
Ameri, Kurosh ;
Harris, Adrian L. .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2008, 40 (01) :14-21
[2]   Optimisation of the cellular metabolism of glycosylation for recombinant proteins produced by mammalian cell systems [J].
Butler, M. .
CYTOTECHNOLOGY, 2006, 50 (1-3) :57-76
[3]  
Champion KM, 1999, ELECTROPHORESIS, V20, P994, DOI 10.1002/(SICI)1522-2683(19990101)20:4/5<994::AID-ELPS994>3.0.CO
[4]  
2-N
[5]   Development and Production of Commercial Therapeutic Monoclonal Antibodies in Mammalian Cell Expression Systems: An Overview of the Current Upstream Technologies [J].
Chartrain, Michel ;
Chu, Lily .
CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2008, 9 (06) :447-467
[6]   Genetic characterization of CHO production host DG44 and derivative recombinant cell lines [J].
Derouazi, M ;
Martinet, D ;
Schmutz, NB ;
Flaction, R ;
Wicht, M ;
Bertschinger, M ;
Hacker, DL ;
Beckmann, JS ;
Wurm, FM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 340 (04) :1069-1077
[7]   Engineering mammalian cell factories for improved recombinant monoclonal antibody production: Lessons from nature? [J].
Dinnis, DM ;
James, DC .
BIOTECHNOLOGY AND BIOENGINEERING, 2005, 91 (02) :180-189
[8]   Transcriptional profiling of gene expression changes in a PACE-transfected CHO DUKX cell line secreting high levels of rhBMP-2 [J].
Doolan, Padraig ;
Melville, Mark ;
Gammell, Patrick ;
Sinacore, Martin ;
Meleady, Paula ;
McCarthy, Kevin ;
Francullo, Linda ;
Leonard, Mark ;
Charlebois, Timothy ;
Clynes, Martin .
MOLECULAR BIOTECHNOLOGY, 2008, 39 (03) :187-199
[9]   Effect of static pressure on intracellular pH of adhesive Chinese hamster ovary cells [J].
Fujiwara, Masashi ;
Koizumi, Satoru ;
Takagi, Mutsurni .
JOURNAL OF BIOSCIENCE AND BIOENGINEERING, 2007, 104 (06) :510-512
[10]   Comparative transcriptional analysis of mouse hybridoma and recombinant Chinese hamster ovary cells undergoing butyrate treatment [J].
Gatti, Marcela De Leon ;
Wlaschin, Katie F. ;
Nissom, Peter Morin ;
Yap, Miranda ;
Hu, Wei-Shou .
JOURNAL OF BIOSCIENCE AND BIOENGINEERING, 2007, 103 (01) :82-91